Pineapple Express Cannabis (PNXP) Depreciation and Depletion (2018 - 2024)
Pineapple Express Cannabis' (PNXP) quarterly Depreciation and Depletion came in at $115.0 in Q4 2024, little changed year-on-year from $115.0 in Q4 2023, and little changed quarter-over-quarter from $115.0 in Q3 2024.
Pineapple Express Cannabis (PNXP) Depreciation and Depletion (2018 - 2024) Analysis & Trends
Pineapple Express Cannabis has disclosed Depreciation and Depletion across 7 years of filings, most recently posting $115.0 for Q4 2024.
- Depreciation and Depletion for Q4 2024 came in at $115.0, changed 0.0% year-over-year; the trailing twelve-month figure through Jul 2025 was $115.0 (down 75.0% YoY), and the FY2025 annual result was $345.0, down 25.0% from the prior year.
- Depreciation and Depletion came in at $115.0 for Q4 2024 at Pineapple Express Cannabis, roughly flat from $115.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $6599.0 in Q4 2020 to a low of $115.0 in Q2 2023.
- The 5-year median for Depreciation and Depletion is $938.5 (2022), against an average of $1893.9.
- Across the five-year window, Depreciation and Depletion soared 590.69% in 2022 and sank 87.75% in 2023, its largest moves.
- Pineapple Express Cannabis' Depreciation and Depletion stood at $6599.0 in 2020, then sank by 36.98% to $4159.0 in 2021, then plunged by 77.42% to $939.0 in 2022, then tumbled by 87.75% to $115.0 in 2023, then changed by 0.0% to $115.0 in 2024.
- The last three Depreciation and Depletion figures came in at $115.0 (Q4 2024), $115.0 (Q3 2024), and $115.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Pineapple Express Cannabis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2024 | 115.00 |
| Oct 31, 2024 | 115.00 |
| Jul 31, 2024 | 115.00 |
| Jul 31, 2024 | 115.00 |
| Apr 30, 2024 | 115.00 |
| Apr 30, 2024 | 115.00 |
| Jan 31, 2024 | 115.00 |
| Jan 31, 2024 | 115.00 |
| Oct 31, 2023 | 115.00 |
| Oct 31, 2023 | 115.00 |
| Jul 31, 2023 | 115.00 |
| Jul 31, 2023 | 115.00 |
| Apr 30, 2023 | 115.00 |
| Apr 30, 2023 | 115.00 |
| Oct 31, 2022 | 939.00 |
| Oct 31, 2022 | 939.00 |
| Jul 31, 2022 | 939.00 |
| Jul 31, 2022 | 939.00 |
| Apr 30, 2022 | 938.00 |
| Apr 30, 2022 | 938.00 |